Tivozanib Completed Phase 1 Trials for Advanced Solid Tumors / Locally Advanced or Metastatic Breast or Colorectal Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01306630A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors